IDEXX Laboratories Inc. logo

IDEXX Laboratories Inc.

IDXX | NASDAQ
Chart Builder DCF Calculator
$507.61
-$4.04 (-0.79%)
Sep 21, 2026, 9:39 AM ET · Market open

Company Profile

IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.

Key Executives

Name Position
Michael Erickson President, Chief Executive Officer & Director
Andrew Emerson Executive Vice President, Chief Financial Officer & Treasurer
Amit Gupta Senior VP, Chief Digital & Information Officer
Bob Asmann Senior Vice President of Global Operations
Jonathan J. Mazelsky Executive Chairman
Julie Godon Senior Vice President & Global Marketing Officer
Martin Smith Executive Vice President of Global Operations and R&D
Michael J. Lane Executive Vice President and GM Global Reference Laboratories, Diagnostic Solutions & Information Technology
Michael Johnson Executive Vice President & Chief Human Resources Officer
Nimrata Khatra Hunt Advisor
Sharon E. Underberg Executive Vice President, General Counsel, & Corporate Secretary

Latest SEC Filings

Date Type Title
Aug 24, 2026 4 Filing
Aug 04, 2026 10-Q Quarterly Report
Aug 04, 2026 8-K Current Report
Aug 03, 2026 4 Filing
Jun 02, 2026 4 Filing
Jun 01, 2026 SD Filing
May 15, 2026 8-K Current Report
May 14, 2026 4 Filing
May 14, 2026 4 Filing
May 14, 2026 4 Filing
View All SEC Filings
IDEXX Laboratories Inc.
IDEXX Laboratories Inc. logo
Country United States
IPO Date Jun 20, 1991
Industry Medical - Diagnostics & Research
Sector Healthcare
Employees 11,000
CEO Michael Erickson

Contact Details

One IDEXX Drive Westbrook, Maine 04092 United States

Stock Details

Ticker Symbol IDXX
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000874716
CUSIP Number 45168D104
ISIN Number US45168D1046
SIC Code 2835

© 2026 bestshares.com. All rights reserved.